Retatrutide is a synthetic peptide agonist of three incretin and energy-balance receptors: GLP-1, GIP, and glucagon. It is investigated in preclinical metabolic research for its interactions with incretin signalling, energy expenditure, and adiposity.
- Triple GLP-1 / GIP / glucagon receptor agonism
- Studied in incretin and energy-balance research
- HPLC-verified, lyophilised powder
Supplied strictly for laboratory research purposes only. Not for human consumption, medical use, or veterinary application. Not approved by the MHRA. By purchasing, you confirm use in a qualified research environment.
Reviews
There are no reviews yet.